Pharmafile Logo
Pharmafocus logo
Advanced Search

pharma

Showing 15 posts of 2914 posts found.

Philip Hampton to step down from chairman role at GSK

January 28, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, UK, appointment, pharma

Sir Philip Hampton is stepping down from his role as non-executive chairman of British multinational GlaxoSmithKline. The resignation comes just …

Appointment

Novartis warns of huge impact of no-deal Brexit

January 28, 2019
Sales and Marketing EU, Novartis, UK, brexit, no-deal, pharma

Swiss pharmaceutical company Novartis has called on the British government to ‘ensure continuity of supply’ in the case of a …

News
dw-anzcxqaqavhl

Head of opioid advisory panel criticises FDA for complacency in ongoing crisis

January 28, 2019
Medical Communications, Sales and Marketing Dsuvia, FDA, opioid crisis, opioids, pharma

The opioid crisis continues to be a top healthcare concern in the US, but the head of the FDA’s Anesthetic …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

January 25, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Celgene, NHS, health, pharma, venlytxo

While American firm AbbVie gained approval for leukaemia drug Venlytxo, the NHS defeated the US multinational thus week in court, …

News
amgen_flag

China’s NMPA approves Amgen’s Repatha to reduce cardiovascular event risk

January 25, 2019
Medical Communications, Sales and Marketing Amgen, China, Repatha, cardiovascular disease, pharma, stroke

Amgen has announced that its proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor Repatha (evolocumab) has secured approval by China’s drug …

News
nhs_sign

NHS App begins public rollout across England following successful testing

January 24, 2019
Medical Communications England, NHS, NHS App, UK, health, pharma

NHS England has announced that the NHS app, which will allow patients to book and manage their GP appointments alongside …

News

EMA rejects Lilly’s Lartruvo in soft tissue cancer following trial failure

January 24, 2019
Sales and Marketing Cancer, EMA, Eli Lilly, Lartruvo, pharma

Eli Lilly has been dealt a blow as the European Medicines Agency announced its recommendation for soft tissue cancer patients …

News
amgen_hq

Amgen’s Blincyto secures expanded indication in Europe for acute lymphoblastic leukaemia

January 23, 2019
Research and Development, Sales and Marketing Ammgen, Cancer, Europe, European Commission, blincyto, leukaemia, pharma

The European Commission has chosen to expand the authorised indication for Amgen’s Blincyto (blinatumomab) in the region, it has emerged, …

News

Including prices on TV ads only works when the price is listed alone

January 23, 2019
Research and Development Trump, USA, pharma, pricing

Requiring pharmaceutical companies to publish the price of their drugs on adverts on TV, would probably not help to control …

News
samsung

FDA approves third Herceptin biosimilar with Samsung Bioepis’ Ontruzant

January 22, 2019
Manufacturing and Production, Sales and Marketing FDA, Herceptin, Samsung Bioepis, biosimilar, pharma

Samsung Bioepis’ has announced that the FDA has chosen to approve Ontruzant (trastuzumab-dttb), its biosimilar version of Roche’s Herceptin (trastuzumab), …

News
bi_german_building_at_night

Boehringer expands manufacturing facility in Shanghai

January 22, 2019
Manufacturing and Production Boehringer Ingelheim, China, Shanghai, facilities, manufacturing, pharma

German firm Boehringer Ingelheim has expanded the capacity of its commercial manufacturing site for biologics in Shanghai, China. The expansion …

News
vertex-headquarters

Vertex’s Orkambi can be used in even younger cystic fibrosis patients, says European Commission

January 22, 2019
Manufacturing and Production, Sales and Marketing Orkambi, Vertex, cystic fibrosis, pharma

Vertex has announced that the European Commission has decided to approve a label extension in the region for Orkambi (lumacaftor/ivacaftor) …

News
mesothelioma

Pushing for progress in mesothelioma

January 21, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, mesothelioma, pharma

Mesothelioma.net reviews the wide array of latest advances in treatment and care for patients affected by the challenging cancer as …

Feature
lilly_building_with_american_flag_web

Lilly’s Lartruvo/chemo combo surprises with Phase 3 failure in soft tissue carcinoma

January 21, 2019
Research and Development, Sales and Marketing Cancer, Eli Lilly, carcinoma, chemotherapy, pharma, trial failure

Eli Lilly has reluctantly pulled back the curtain on new Phase 3 data for its platelet-derived growth factor receptor alpha …

News
imp_pologne2

NICE recommends Pierre Fabre’s Braftovi in BRAF V600-mutated advanced melanoma

January 21, 2019
Sales and Marketing Braftovi, Cancer, NICE, Pierre Fabre, UK, melanoma, pharma

Braftovi (encorafenib), a BRAF kinase inhibitor developed by Pierre Fabre, has been awarded approval in combination with Mektovi (binimetinib) by …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026